Persistence of B19 IgG After BMT in Relation to Prior Recipient and Donor Immunity
. | B19 IgG . | Proportion Seropositive at 2-3 yr Post-BMT . | Years Serum Received Post-BMT . | ||
---|---|---|---|---|---|
. | Pre-BMT . | . | Median . | Range . | |
. | Recipient . | Donor . | . | . | . |
Group A | − | − | 2/13 | 2 | 2-3 |
Group B | − | + | 1/15 | 2 | 2-3 |
Total | 3/28* | ||||
Group C | + | − | 10/16 | 2 | 2-3 |
Group D | + | + | 12/22 | 2 | 2-3.5 |
Total | 22/38* |
. | B19 IgG . | Proportion Seropositive at 2-3 yr Post-BMT . | Years Serum Received Post-BMT . | ||
---|---|---|---|---|---|
. | Pre-BMT . | . | Median . | Range . | |
. | Recipient . | Donor . | . | . | . |
Group A | − | − | 2/13 | 2 | 2-3 |
Group B | − | + | 1/15 | 2 | 2-3 |
Total | 3/28* | ||||
Group C | + | − | 10/16 | 2 | 2-3 |
Group D | + | + | 12/22 | 2 | 2-3.5 |
Total | 22/38* |
Difference between these two proportions significant (P = .0003).